Valley National Advisers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Valley National Advisers’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-125	Closed	-$15K	–	769
2019 Q3	$15K	Hold	125	–	–	﹤0.01%	463
2019 Q2	$18K	Hold	125	–	–	﹤0.01%	413
2019 Q1	$19K	Sell	125 -73	-37%	-$10.5K	0.01%	398
2018 Q4	$25K	Buy	198 +73	+58%	+$9.98K	0.01%	331
2018 Q3	$20K	Hold	125	–	–	0.01%	356
2018 Q2	$18K	Hold	125	–	–	0.01%	360
2018 Q1	$17K	Hold	125	–	–	0.01%	348
2017 Q4	$16K	Hold	125	–	–	0.01%	359
2017 Q3	$15K	Hold	125	–	–	0.01%	363
2017 Q2	$14K	Buy	+125	New	+$13.4K	0.01%	362

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Valley National Advisers's FBT Position: Q4 2019 in Review

Valley National Advisers sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2019, closing a stake of 125 shares — an estimated $15K sold.

Valley National Advisers first reported a position in FBT in Q2 2017 and held it in 10 quarters. The position peaked at $25K in Q4 2018. 210 funds tracked by Wall St. Rank hold FBT as of Q4 2019.

Valley National Advisers reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2019 after selling out during the quarter.
Valley National Advisers sold 125 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2019, an estimated $15K.
Valley National Advisers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and held it in 10 quarters.
Valley National Advisers's First Trust NYSE Arca Biotechnology Index Fund position peaked at $25K in Q4 2018.
210 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2019.

Based on Valley National Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.